1 completed, 1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow GILongevity: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Effects of the Combination of GI-102 With GIB-7 on Biomarkers of Aging in Healthy Adults and Cancer Survivors GI-102 in combination with GIB-7, Placebo - Cancer Survivors, Healthy Participant | Phase 2 | Recruiting | GI Innovation, Inc. | 15 | 2026-01-01 | 2026-01-26 |
| Live Biotherapeutic Product GB104 Phase 1 Study in Colorectal Cancer GB104(Level 1), GB104(Level 2), GB104(Level 3) - Solid Tumor, Colorectal Cancer | Phase 1 | Completed | GILongevity | 9 | 2023-04-28 | 2025-02-14 |
Colorectal Neoplasms (1) · Neoplasms (1) · Rectal Neoplasms (1) · Sigmoid Neoplasms (1)
Australia (1) · South Korea (1)